
Sep 2, 2026
PixCell Medical Expands into Canada Through Partnership with Inter Medico Following Health Canada Class III Licence for HemoScreen
YOKNEAM ILIT, Israel, Sept. 2, 2026 /CNW/ -- PixCell Medical today announced its expansion into the Canadian market following the receipt of a Health Canada Class III Medical Device License for its HemoScreen™ point-of-care hematology analyzer and a new distribution partnership with Inter Medico. Building on the company's recent Medical Device Single Audit Program (MDSAP) certification, the milestone enables healthcare providers across Canada to adopt HemoScreen for rapid, lab-quality Complete B







